BIOA BioAge Labs, Inc. - Common Stock
$10,85
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 5, 2026
Rango 52S
$4–$26
30% of range
Calificación del Analista
STRONG BUY
15 analysts
Precio Objetivo
$36
+228% upside
P/E (TTM)
-5.8
ROE
-28.4%
Margen de Beneficio Neto
-896.1%
BIOA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$10.85
Capitalización Bursátil
$482M
P/E (TTM)
-5.8
BPA (TTM)
$-2.24
Ingresos (TTM)
$9M
Rendimiento div.
—
ROE
-28.4%
Deuda/Capital
0.0
Rango 52S
$4 – $26
BIOA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$9M
2024-12-31
→
2025-12-31
BPA
$-2.24
2023-12-31
→
2025-12-31
Flujo de caja libre
$-82M
2024-12-31
→
2025-12-31
Márgenes
-896.1%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
BIOA
Mediana de Pares
P/E (TTM)
-5.8
11.7
P/S (TTM) (P/V (TTM))
53.5
5.4
P/B (P/C)
1.8
3.7
EV / EBITDA
-2.2
—
Price / FCF (Precio / FCF)
-5.8
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
BIOA
Mediana de Pares
Operating Margin (Margen Operativo)
-1031.5%
—
Net Profit Margin (Margen de Beneficio Neto)
-896.1%
-45.6%
ROA
-24.7%
-25.4%
ROE
-28.4%
-27.1%
ROIC
-33.8%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
BIOA
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
0.0
—
Current Ratio (Ratio corriente)
14.2
4.6
Quick Ratio (Ratio Rápido)
14.0
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
BIOA
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
BIOA
Mediana de Pares
BIOA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
15 analistas
- Compra fuerte 6 40,0%
- Compra 6 40,0%
- Mantener 3 20,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
8 analistas · 2026-08-17
Mediana
$30.00
Media
$35.62
← Por Debajo de Todos los Objetivos
$10.85
Mín
$20.00
Máx
$73.00
Objetivo mediano
$30.00
+176,5%
Objetivo medio
$35.62
+228,3%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.07%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.58 | $-0.62 | 0.04% |
| 31 de marzo de 2026 | $-0.52 | $-0.65 | 0.13% |
| 31 de diciembre de 2025 | $-0.72 | $-0.75 | 0.03% |
| 30 de septiembre de 2025 | $-0.56 | $-0.60 | 0.04% |
| 30 de junio de 2025 | $-0.60 | $-0.49 | -0.11% |
| 31 de marzo de 2025 | $-0.36 | $-0.54 | 0.18% |
| 31 de diciembre de 2024 | $-1.97 | $-2.12 | 0.15% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | $9M | $0 | |
| R&D Expense | $74M | $59M | |
| SG&A Expense | $28M | $19M | |
| Operating Expenses | $102M | $78M | |
| Operating Income | $-93M | $-78M | |
| Other Non-op | $12M | $7M | |
| Pretax Income | $-81M | $-71M | |
| Income Tax | $0 | $0 | |
| Net Income | $-81M | $-71M | |
| EPS (Basic) | $-2.24 | $-6.63 | |
| EPS (Diluted) | $-2.24 | $-6.63 | |
| Shares (Basic) | 35,932,914 | 10,726,521 | |
| Shares (Diluted) | 35,932,914 | 10,726,521 | |
| EBITDA | $-93M | $-78M |
Balance general 23
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $189M | $354M | |
| Short-term Investments | $92M | $0 | |
| Receivables | $769.0K | $0 | |
| Prepaid Expense | $5M | $3M | |
| Current Assets | $287M | $357M | |
| PP&E (Net) | $963.0K | $591.0K | |
| PP&E (Gross) | $1M | $962.0K | |
| Accum. Depreciation | $482.0K | $371.0K | |
| Other Non-current Assets | $216.0K | $240.0K | |
| Total Assets | $295M | $358M | |
| Accounts Payable | $3M | $2M | |
| Current Liabilities | $20M | $28M | |
| Capital Leases | $2M | $0 | |
| Total Liabilities | $23M | $35M | |
| Long-term Debt | $3M | $9M | |
| Total Debt | $3M | $9M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $605M | $576M | |
| Retained Earnings | $-333M | $-253M | |
| AOCI | $278.0K | $245.0K | |
| Stockholders' Equity | $272M | $323M | |
| Liabilities + Equity | $295M | $358M | |
| Shares Outstanding | 37,386,908 | 35,850,037 |
Flujo de Efectivo 10
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $12M | $7M | |
| Operating Cash Flow | $-82M | $-52M | |
| CapEx | $719.0K | $366.0K | |
| Investing Cash Flow | $-95M | $-366.0K | |
| Stock Issued | $17M | $0 | |
| Net Stock Activity | $17M | · | |
| Financing Cash Flow | $11M | $381M | |
| Net Change in Cash | $-165M | $329M | |
| Taxes Paid | $0 | $0 | |
| Free Cash Flow | $-82M | $-52M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1031.5% | · | |
| Net Margin | -896.1% | · | |
| Pretax Margin | -896.1% | · | |
| EBITDA Margin | -1031.5% | · | |
| ROA | -24.7% | -37.0% | |
| ROE | -28.4% | -22.3% | |
| ROIC | -33.8% | -23.6% |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 14.2 | 12.9 | |
| Quick Ratio | 14.0 | 12.8 | |
| Debt / Equity | 0.0 | 0.0 | |
| LT Debt / Equity | 0.0 | 0.0 |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 23.4 | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $9M | $0 | |
| Net Income TTM | $-81M | $-71M | |
| Market Cap | $495M | $208M | |
| Enterprise Value | $216M | $-138M | |
| P/E | -5.9 | -0.9 | |
| P/S | 55.0 | · | |
| P/B | 1.8 | 0.6 | |
| P / Tangible Book | 1.8 | 0.6 | |
| P / Cash Flow | -6.1 | -4.0 | |
| P / FCF | -6.0 | -4.0 | |
| EV / EBITDA | -2.3 | 1.8 | |
| EV / FCF | -2.6 | 2.7 | |
| EV / Revenue | 24.0 | · | |
| Earnings Yield | -16.9% | -114.5% |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $3M | $3M | $2M | $2M | $1M | $0 | $0 | $0 | |
| R&D Expense | $24M | $20M | $24M | $19M | $20M | $11M | $19M | $20M | $10M | |
| SG&A Expense | $7M | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | |
| Operating Expenses | $32M | $28M | $32M | $25M | $27M | $18M | $25M | $25M | $15M | |
| Operating Income | $-29M | $-25M | $-28M | $-23M | $-25M | $-16M | $-25M | $-25M | $-15M | |
| Other Non-op | $3M | $3M | $2M | $3M | $3M | $4M | $4M | $1M | $2M | |
| Net Income | $-26M | $-22M | $-26M | $-20M | $-22M | $-13M | $-21M | $-23M | $-14M | |
| EPS (Basic) | $-0.58 | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| EPS (Diluted) | $-0.58 | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| Shares (Basic) | 44,838,893 | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| Shares (Diluted) | 44,838,893 | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| EBITDA | $-29M | $-25M | · | $-23M | $-25M | $-16M | · | $-25M | · |
Balance general 23
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $242M | $189M | $216M | $220M | $257M | $354M | $334M | · | |
| Short-term Investments | $245M | $141M | $92M | $70M | $77M | $63M | $0 | · | · | |
| Receivables | $625.0K | $709.0K | $769.0K | $515.0K | $603.0K | $361.0K | $0 | · | · | |
| Prepaid Expense | $11M | $8M | $5M | $5M | $4M | $4M | $3M | $2M | · | |
| Current Assets | $330M | $392M | $287M | $291M | $302M | $325M | $357M | $336M | · | |
| PP&E (Net) | $1M | $1M | $963.0K | $973.0K | $974.0K | $929.0K | $591.0K | $543.0K | · | |
| PP&E (Gross) | $2M | $2M | $1M | $1M | $1M | $1M | $962.0K | $1M | · | |
| Accum. Depreciation | $613.0K | $543.0K | $482.0K | $413.0K | $462.0K | $408.0K | $371.0K | $540.0K | · | |
| Other Non-current Assets | $208.0K | $215.0K | $216.0K | $227.0K | $237.0K | $239.0K | $240.0K | · | · | |
| Total Assets | $397M | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Accounts Payable | $6M | $3M | $3M | $5M | $1M | $4M | $2M | $2M | · | |
| Current Liabilities | $19M | $16M | $20M | $24M | $23M | $24M | $28M | $19M | · | |
| Capital Leases | $2M | $2M | $2M | $2M | $3M | $3M | $0 | · | · | |
| Total Liabilities | $22M | $19M | $23M | $28M | $27M | $31M | $35M | $24M | · | |
| Long-term Debt | · | · | $3M | $4M | $6M | $7M | $9M | $10M | · | |
| Total Debt | $0 | $1M | · | $4M | $6M | $7M | · | $10M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | · | $0 | · | · | |
| Paid-in Capital | $757M | $735M | $605M | $585M | $582M | $579M | $576M | $545M | · | |
| Retained Earnings | $-382M | $-356M | $-333M | $-307M | $-287M | $-266M | $-253M | $-232M | · | |
| AOCI | $-478.0K | $73.0K | $278.0K | $275.0K | $212.0K | $264.0K | $245.0K | $109.0K | · | |
| Stockholders' Equity | $375M | $379M | $272M | $277M | $295M | $313M | $323M | $314M | · | |
| Liabilities + Equity | $397M | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Shares Outstanding | 45,776,902 | 44,386,785 | 37,386,908 | 35,850,037 | 35,850,037 | 35,850,037 | 35,850,037 | 34,196,821 | · |
Flujo de Efectivo 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Operating Cash Flow | $-19M | $-24M | $-28M | $-16M | $-20M | $-17M | $-5M | $-15M | $-16M | |
| CapEx | $328.0K | $26.0K | $112.0K | $22.0K | $159.0K | $426.0K | $26.0K | $305.0K | $35.0K | |
| Investing Cash Flow | $-165M | $-47M | $-14M | $13M | $-16M | $-78M | $-26.0K | $-305.0K | $-35.0K | |
| Financing Cash Flow | $16M | $124M | $16M | $-2M | $-2M | $-2M | $25M | $191M | $-2M | |
| Net Change in Cash | $-168M | $53M | $-27M | $-5M | $-37M | $-97M | $20M | $175M | $-18M | |
| Free Cash Flow | · | $-24M | · | · | · | $-18M | · | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1196.8% | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| Net Margin | -1064.8% | -802.8% | · | -982.0% | -894.0% | -891.0% | · | · | · | |
| EBITDA Margin | -1196.8% | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| ROA | -7.3% | -6.0% | · | -6.3% | -13.4% | -7.5% | · | -13.9% | · | |
| ROE | -7.8% | -6.4% | · | -6.8% | -14.6% | -8.3% | · | -14.9% | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.2 | 24.8 | · | 11.9 | 13.2 | 13.7 | · | 17.6 | · | |
| Quick Ratio | 16.6 | 24.3 | · | 11.7 | 13.0 | 13.5 | · | 17.5 | · | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | |
| Receivables Turnover | 4.0 | 5.2 | · | 8.0 | 8.0 | 8.0 | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $9M | · | $6M | $4M | · | · | · | · | |
| Net Income TTM | $-90M | $-77M | · | $-78M | $-71M | $-63M | · | $-65M | · | |
| Market Cap | $1.12B | $776M | · | $211M | $148M | $135M | · | $711M | · | |
| Enterprise Value | $803M | $394M | · | $-71M | $-144M | $-179M | · | $387M | · | |
| P/E | -10.8 | -8.6 | · | -0.7 | -0.3 | -0.2 | · | -0.7 | · | |
| P/S | 115.8 | 89.3 | · | 35.6 | 38.3 | · | · | · | · | |
| P/B | 3.0 | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Tangible Book | 3.0 | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Cash Flow | · | -32.3 | · | · | · | -7.8 | · | · | · | |
| P / FCF | · | -32.3 | · | · | · | -7.6 | · | · | · | |
| EV / EBITDA | -27.4 | -15.5 | · | 3.1 | 5.8 | 10.9 | · | -15.6 | · | |
| EV / FCF | · | -16.4 | · | · | · | 10.0 | · | · | · | |
| EV / Revenue | 82.9 | 45.4 | · | -12.0 | -37.2 | · | · | · | · | |
| Earnings Yield | -9.2% | -11.7% | · | -139.8% | -377.7% | -605.3% | · | -149.7% | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ingresos | $9M | $0 | — |
| Margen Operativo % | -1031.5% | — | — |
| Beneficio neto | $-81M | $-71M | $-64M |
| EPS Diluido | $-2.24 | $-6.63 | $-38.17 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Deuda / Patrimonio | 0.0 | 0.0 | — |
| Ratio corriente | 14.2 | 12.9 | — |
| Ratio Rápido | 14.0 | 12.8 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $-82M | $-52M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 169 declarantes · $825.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 42 (-11 vs trimestre anterior) | 19 (+3 vs trimestre anterior) | 51 (+7 vs trimestre anterior) | 43 (+18 vs trimestre anterior) | +1.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| a16z Capital Management, L.L.C. | $79 244 997 | 3 233 170 | 9,60% | Acciones |
| Cormorant Asset Management, LP | $58 593 729 | 2 390 605 | 7,10% | Acciones |
| Sofinnova Investments, Inc. | $56 220 744 | 2 293 788 | 6,81% | Acciones |
| Octagon Capital Advisors LP | $42 843 480 | 1 748 000 | 5,19% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $40 972 092 | 1 671 648 | 4,96% | Acciones |
| MPM BIOIMPACT LLC | $40 874 371 | 1 667 661 | 4,95% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $37 848 685 | 1 544 214 | 4,59% | Acciones |
| JANUS HENDERSON GROUP PLC | $36 597 368 | 2 094 270 | 4,43% | Acciones |
| Polar Capital Holdings Plc | $26 283 151 | 1 072 344 | 3,18% | Acciones |
| BRAIDWELL LP | $25 321 992 | 1 033 129 | 3,07% | Acciones |
| STATE STREET CORP | $25 036 083 | 1 021 464 | 3,03% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $21 542 373 | 878 729 | 2,61% | Acciones |
| Sands Capital Alternatives, LLC | $19 273 512 | 786 353 | 2,34% | Acciones |
| ORBIMED ADVISORS LLC | $18 435 270 | 752 153 | 2,23% | Acciones |
| Balyasny Asset Management L.P. | $17 227 050 | 702 858 | 2,09% | Acciones |
| D. E. Shaw & Co., Inc. | $16 771 139 | 684 257 | 2,03% | Acciones |
| VANGUARD GROUP INC | $16 418 324 | 1 240 992 | 1,99% | Acciones |
| Pivotal bioVenture Partners Investment Advisor LLC | $16 014 197 | 653 374 | 1,94% | Acciones |
| COSMIC MANAGEMENT, LLC | $12 299 927 | 501 833 | 1,49% | Acciones |
| STEMPOINT CAPITAL LP | $11 376 831 | 464 171 | 1,38% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10 053 144 | 410 165 | 1,22% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $9 242 353 | 377 085 | 1,12% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $8 778 158 | 358 146 | 1,06% | Acciones |
| Walleye Capital LLC | $8 686 221 | 354 395 | 1,05% | Acciones |
| Integral Health Asset Management, LLC | $7 353 000 | 300 000 | 0,89% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7 353 000 | 300 000 | 0,89% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7 267 215 | 296 500 | 0,88% | Opción de compra |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6 700 323 | 273 371 | 0,81% | Acciones |
| Comprehensive Financial Management LLC | $6 662 847 | 271 842 | 0,81% | Acciones |
| BANK OF AMERICA CORP /DE/ | $6 320 026 | 257 855 | 0,77% | Acciones |
| Squadron Capital Management LLC | $6 127 500 | 250 000 | 0,74% | Opción de compra |
| MILLENNIUM MANAGEMENT LLC | $5 456 441 | 222 621 | 0,66% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $5 382 396 | 219 600 | 0,65% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $5 237 076 | 213 671 | 0,63% | Acciones |
| DIADEMA PARTNERS LP | $4 904 451 | 200 100 | 0,59% | Opción de compra |
| Ikarian Capital, LLC | $4 901 999 | 200 000 | 0,59% | Acciones |
| GOLDMAN SACHS GROUP INC | $4 599 081 | 187 641 | 0,56% | Acciones |
| FMR LLC | $4 499 129 | 183 563 | 0,55% | Acciones |
| Yiheng Capital Management, L.P. | $4 179 739 | 170 532 | 0,51% | Acciones |
| MORGAN STANLEY | $4 071 430 | 166 113 | 0,49% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $4 061 307 | 165 700 | 0,49% | Acciones |
| Squadron Capital Management LLC | $3 799 050 | 155 000 | 0,46% | Acciones |
| DIADEMA PARTNERS LP | $3 586 646 | 146 334 | 0,43% | Acciones |
| Ensign Peak Advisors, Inc | $3 473 018 | 141 698 | 0,42% | Acciones |
| UBS Group AG | $2 522 716 | 102 926 | 0,31% | Acciones |
| NEXTBio Capital Management LP | $2 468 941 | 100 732 | 0,30% | Acciones |
| Burkehill Global Management, LP | $2 451 000 | 100 000 | 0,30% | Acciones |
| Alessandra Capital Management, LLC | $2 288 459 | 93 368 | 0,28% | Acciones |
| CITADEL ADVISORS LLC | $1 920 726 | 78 365 | 0,23% | Acciones |
| Caption Management, LLC | $1 838 250 | 75 000 | 0,22% | Opción de compra |
| BNP PARIBAS FINANCIAL MARKETS | $1 752 146 | 71 487 | 0,21% | Acciones |
| Birchview Capital, LP | $1 691 190 | 69 000 | 0,20% | Acciones |
| Squarepoint Ops LLC | $1 677 366 | 68 436 | 0,20% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 504 767 | 61 394 | 0,18% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 504 424 | 61 380 | 0,18% | Acciones |
| AMERIPRISE FINANCIAL INC | $1 450 943 | 59 198 | 0,18% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 431 384 | 58 400 | 0,17% | Opción de venta |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 422 193 | 58 025 | 0,17% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $1 342 658 | 54 780 | 0,16% | Acciones |
| Quantinno Capital Management LP | $1 254 618 | 51 188 | 0,15% | Acciones |
| SEVEN GRAND MANAGERS, LLC | $1 225 500 | 50 000 | 0,15% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1 214 348 | 49 545 | 0,15% | Acciones |
| Moody Aldrich Partners LLC | $1 164 004 | 47 491 | 0,14% | Acciones |
| SIMPLEX TRADING, LLC | $1 158 832 | 47 280 | 0,14% | Acciones |
| Bank of New York Mellon Corp | $1 118 416 | 45 631 | 0,14% | Acciones |
| RHUMBLINE ADVISERS | $1 076 080 | 43 904 | 0,13% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1 029 420 | 42 000 | 0,12% | Acciones |
| Corient Private Wealth LP | $986 724 | 40 778 | 0,12% | Acciones |
| BlackRock, Inc. | $985 400 | 40 204 | 0,12% | Acciones |
| Persistent Asset Partners Ltd | $913 071 | 37 253 | 0,11% | Acciones |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $866 183 | 35 340 | 0,10% | Acciones |
| DEUTSCHE BANK AG\ | $840 644 | 34 298 | 0,10% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $799 293 | 45 700 | 0,10% | Acciones |
| CITADEL ADVISORS LLC | $794 124 | 32 400 | 0,10% | Opción de venta |
| Militia Capital Management LLC | $791 330 | 32 286 | 0,10% | Acciones |
| Vanguard Global Advisers, LLC | $781 011 | 31 865 | 0,09% | Acciones |
| MARSHALL WACE, LLP | $778 021 | 31 743 | 0,09% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $735 349 | 30 002 | 0,09% | Acciones |
| CITIGROUP INC | $697 138 | 28 443 | 0,08% | Acciones |
| STATE OF WISCONSIN INVESTMENT BOARD | $689 883 | 28 147 | 0,08% | Acciones |
| CITADEL ADVISORS LLC | $681 378 | 27 800 | 0,08% | Opción de compra |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $681 084 | 27 788 | 0,08% | Acciones |
| XTX Topco Ltd | $656 696 | 26 793 | 0,08% | Acciones |
| WEXFORD CAPITAL LP | $631 500 | 25 765 | 0,08% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $612 750 | 25 000 | 0,07% | Opción de compra |
| JANE STREET GROUP, LLC | $590 421 | 24 089 | 0,07% | Acciones |
| Caption Management, LLC | $569 612 | 23 240 | 0,07% | Acciones |
| STRS OHIO | $539 220 | 22 000 | 0,07% | Acciones |
| BARCLAYS PLC | $538 779 | 21 982 | 0,07% | Acciones |
| Militia Capital Partners, LP | $533 169 | 40 300 | 0,06% | Acciones |
| MetLife Investment Management, LLC | $511 989 | 20 889 | 0,06% | Acciones |
| Stonepine Capital Management, LLC | $490 200 | 20 000 | 0,06% | Acciones |
| BANK OF NOVA SCOTIA | $490 200 | 20 000 | 0,06% | Acciones |
| Man Group plc | $444 783 | 18 147 | 0,05% | Acciones |
| Virtus Investment Advisers, LLC | $444 538 | 18 137 | 0,05% | Acciones |
| Verdad Advisers, LP | $426 327 | 17 394 | 0,05% | Acciones |
| JANE STREET GROUP, LLC | $409 317 | 16 700 | 0,05% | Opción de venta |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $396 743 | 16 187 | 0,05% | Acciones |
| GREAT LAKES ADVISORS, LLC | $390 493 | 15 932 | 0,05% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $373 532 | 15 240 | 0,05% | Acciones |
Informantes de la empresa 9 insiders · 3 directivos · 6 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| GOLDSTEIN DOV A MD | Chief Financial Officer | 23 de abril de 2026 M | 36 575 | 0 | 4 | $-531 844 |
| Shane Barton | Principal Accounting Officer | 30 de junio de 2026 M | 0 | 0 | 2 | $-1 576 885 |
| Paul D Rubin | Chief Medical Officer | 1 de abril de 2026 M | 0 | 0 | 6 | $-1 460 917 |
| Vijay Satyanand Pande | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Rekha Hemrajani | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Michael H. Davidson | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Patrick G. Enright | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Dr. James I. Healy | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Jean Pierre Garnier | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| AH Bio Fund I, L.P., AH Equity Partners Bio I, L.L.C., AH Bio Fund III, L.P., AH Equity Partners Bio III, L.L.C., AH Bio Fund IV, L.P., AH Equity Partners Bio IV, L.L.C., Andreessen Horowitz LSV Fund III, L.P., AH Equity Partners LSV III, L.L.C., Marc Andreessen, Benjamin Horowitz | 4 de octubre de 2024 | — | Presentación inicial | Inversión pasiva | SEC |
| Sofinnova Venture Partners XI, L.P. (“SVP XI”), Sofinnova Management XI, L.P. (“SM XI LP”), Sofinnova Management XI, L.L.C. (“SM XI LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) | 30 de septiembre de 2024 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 36 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0,81% | 6 165 NS | 30 de abril de 2026 | N-PORT |
| BIB · ProShares Trust | 0,04% | 1 604 NS | 31 de mayo de 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 43 526 NS | 31 de mayo de 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 10 835 NS | 31 de mayo de 2026 | N-PORT |
| RSSL · Global X Funds | 0,02% | 13 075 NS | 30 de abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1 420 NS | 31 de mayo de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 142 676 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 79 583 NS | 30 de abril de 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1 111 NS | 31 de mayo de 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1 121 NS | 31 de mayo de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 20 675 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 28 NS | 31 de mayo de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1 850 NS | 30 de abril de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 16 108 NS | 31 de mayo de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 13 304 NS | 30 de abril de 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 1 959 NS | 31 de mayo de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 2 074 NS | 30 de abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 893 NS | 30 de abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | — | — | 13 de julio de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 de julio de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| ITOT · iShares Trust | — | — | 5 de agosto de 2026 | Diario |
| IWV · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWN · iShares Trust | — | — | 17 de agosto de 2026 | Diario |
| IWO · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWM · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IBB · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWC · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IHE · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 de julio de 2026 | Diario |
| DWAS · Invesco Exchange-Traded Fund Trust … | — | — | 20 de julio de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 de julio de 2026 | Diario |